Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 76

Daily deal net: February 12, 2021

Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.

Feb 12, 2021

Monad hones $31m series A

The life sciences research technology developer has received funding in a series A round co-led by corporate investor ABclonal.

Feb 12, 2021

Insightin inspires with $12m series A

The healthcare engagement technology provider has received $12m in a round co-led by the Blue Cross Blue Shield-backed Blue Venture Fund.

Feb 12, 2021

Phable tells of $12m series A

Phable, developer of a chronic disease assistance app, has secured funding in a round led by healthcare provider Manipal Hospitals.

Feb 12, 2021

Autocrypt authorises series A round

Penta Security's V2X security software spinoff received nearly $13m from investors including IBK, Kookmin Bank and Hyundai Venture Investment Corp.

Feb 12, 2021

C-Zero seizes series A cash

The gas-to-hydrogen technology developer bagged $11.5m in a round co-led by Eni Next and backed by Mitsubishi Heavy Industries.

Feb 12, 2021

Daily deal net: February 11, 2021

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

Feb 11, 2021

Notch marks $85m series A round

Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.

Feb 11, 2021

Jüsto stacks $65m for series A

The Bimbo and Femsa-backed online grocer has now received over $100m in total, having raised $65m from venture capital investors for its series A round.

Feb 11, 2021

SpyBiotech detects GV for series A round

GV returned for SpyBiotech's $32.5m series A round, as it looks to move its first potential vaccine into the clinic by early next year.

Feb 11, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here